CNBX Pharmaceuticals's total assets for Q2 2025 were $50.66K, an increase of 127.09% from the previous quarter. CNBX total liabilities were $2.62M for the fiscal quarter, a 3.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.